British Group GlaxoSmithKline (GSK) is to close its local factory Europharm in Brasov in March 2016. As a result 200 employees will lose their job. The group announced that the redundant employees will receive severance packages and support to find a new job. Some of the production may be transferred to Spain and Poland.
GSK had announced last year its intention to sell the plant due to over-production in the solid oral formulas.
The plant was set up in 1994 and manufactured drugs for the treatment of HIV/AIDS, respiratory disease, depression, the flu/anti-inflammatory. Later in 1996 the British Group acquired 65% stake in the Romanian factory and the remainder 35% in 2003.